Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Stocks and securities in focus

Security Change (%) 1w 1m 1y YTD 3y ▼ 5y
Cytokinetics Inc. -1.350% -20.000% -27.805% 29.070% -41.961% 146.667% -
Adocia -2.590% -3.813% 4.621% 130.548% -24.915% 1.261% -50.999%
Insmed Inc. 102.970% -10.619% -12.174% 17.442% -29.371% 1.000% -12.174%
ImmunityBio Inc. 3.440% -2.871% -11.302% 155.882% 29.025% -57.702% -
Anavex Life Sciences Corp 2.770% -8.749% 16.288% -56.541% -56.942% -63.748% 7.299%
Cytomx Therapeutics Inc 2.030% -3.783% 10.200% 2.799% 18.410% -71.840% -
B.R.A.I.N. Biotechnology Research and Information Network AG -0.350% 1.060% -0.348% -40.417% -21.429% -71.961% -71.140%
G1 Therapeutics 5.100% -24.940% -12.986% 28.525% 14.036% -82.417% -
Enlivex Therapeutics Ltd. 4.030% -3.876% -7.463% -48.333% -44.643% -83.356% -
Gritstone Oncology Inc 3.020% -2.485% -2.866% -53.522% -59.876% -90.106% -
Verastem Inc. 5.380% -66.786% -56.744% -67.248% -50.728% -90.245% -
Aclaris Therapeutics Inc -2.000% -11.031% -13.627% -87.664% 1.284% -94.412% -
Kala Pharmaceuticals Inc. -2.650% -2.178% 1.565% -58.166% -10.429% -97.454% -
Rhythm Pharmaceuticals -1.760% -4.571% -8.743% 119.737% -21.596% - -
Cymabay Therapeutics Inc - - - - - - -